Medication safety gets a timely spotlight in this health article examining recent reports of dosing mishaps and practical prevention advice.
Key Takeaways
- Poison control calls for semaglutide and other GLP-1 agonists sharply increased after approval
- Researchers attributed most exposures to accidental dosing mistakes rather than intentional misuse
- Authors recommended patient education on weekly dosing and gradual dose escalation to prevent errors